U.S. Moves Marijuana Out of Heroin Category After Decades

After decades of treating marijuana like one of the most dangerous drugs in America, the federal government just made a historic change that could transform healthcare and criminal justice.

The Trump administration announced that some forms of cannabis will move from Schedule I to Schedule III. This means the government no longer considers it as dangerous as heroin, LSD, or MDMA, where it's been classified since 1970.

Acting Attorney General Todd Blanche said state-licensed marijuana and FDA-approved marijuana products now belong in the same category as Tylenol with codeine and ketamine. Schedule III drugs are defined as having "moderate to low" potential for abuse, a major shift from the "high abuse potential" label marijuana has carried for over 50 years.

The change builds on momentum from the Biden administration, which recommended reclassification in 2023 but saw the process stall in court. This time, the DOJ is taking a faster approach to avoid similar delays.

The real breakthrough could come this June. The DOJ announced an expedited hearing to explore full federal rescheduling, a necessary step toward potential nationwide legalization.

The Ripple Effect

This reclassification does more than change a label. It removes massive barriers that have blocked scientists from studying marijuana's medical benefits for decades.

Researchers will now have much easier access to cannabis for clinical trials. Doctors will gain better data to make informed treatment decisions for patients with chronic pain, epilepsy, and other conditions.

The change also signals a dramatic shift in how America approaches drug policy. Millions of Americans live in states where marijuana is already legal, creating a confusing clash between state and federal law that this move begins to address.

For patients who've relied on cannabis for relief but feared federal consequences, this brings real peace of mind. For doctors who wanted to recommend it but worried about their licenses, it offers new freedom.

The road from Schedule III to full legalization isn't guaranteed, but the June hearing represents the most serious federal consideration of marijuana reform in modern history. What once seemed impossible is now on the official agenda.